Please provide your email address to receive an email when new articles are posted on . Patients with benign essential blepharospasm do not have an increased risk of primary open-angle glaucoma, ...
A fascinating new study published in the latest edition of Movements Disorders (Vol.00 No.00, 2016) presents two patient case studies that demonstrate how speaking French as a second language can ...
October 31, 2011 (Orlando, Florida) — A new study shows that shorter injection intervals with incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals), given on an as-needed basis, are safe and effective.
Dear Doctors: I’ve recently been diagnosed with benign essential blepharospasm. Would you please explain what this is? How serious is it? Does it spread? I know it’s not deadly, but I’ve read that it ...
RALEIGH, N.C.--(BUSINESS WIRE)--Merz Americas announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for XEOMIN ® ...
In spring 2001, I was diagnosed with an eye condition that has no known cause and no cure, benign essential blepharospasm (BEB). I couldn't see to walk. I ran into corners and furniture, and I ...
Q I’ve recently been diagnosed with benign essential blepharospasm. Would you please explain what this is? How serious is it? Does it spread? I know it’s not deadly, but I’ve read that it can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results